Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen
Clinical trial NCT00320229 · TERMINATED
Trial details
- NCT number
- NCT00320229
- Sponsor
- Azienda Sanitaria Ospedaliera
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.